Mechanisms of Action of Probiotics

Advances in Nutrition

Volumn 10, Issue , 2019, Pages S49-S66

  Plaza Diaz, Julio ^a,b   Ruiz Ojeda, Francisco Javier ^a,b   Gil Campos, Mercedes ^c,d   Gil, Angel ^a,b,c  

^a UNIVERSITY OF GRANADA   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^c Instituto de Salud Carlos III   (Spain)

^d HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

bifidobacteria; brain gut axis; immune system; lactic acid bacteria; lactobacilli; mechanism of action; probiotics; volatile fatty acids

Indexed keywords

EID: 85061154637     PISSN: 21618313     EISSN: 21565376     Source Type: Journal    
DOI: 10.1093/advances/nmy063     Document Type: Conference Paper

References (162)

1. Food and Agriculture Organization/World Health Organization. Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Cordoba, Argentina: American Cordoba Park Hotel. Rome, Italy: FAO/WHO; 2001. p. 1-2.
2. Roberfroid MB. Prebiotics and probiotics: are they functional foods? Am J Clin Nutr 2000;71:1682-7.
3. Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, Morelli L, Canani RB, Flint HJ, Salminen S, et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 2014;11:506-14.
4. Plaza-Diaz J, Ruiz-Ojeda FJ, Gil-CamposM, Gil A. Immune-mediated mechanisms of action of probiotics and synbiotics in treating pediatric intestinal diseases. Nutrients 2018;10(1):42.
5. Plaza-Diaz J, Robles-Sanchez C, Abadia-Molina F, Saez-Lara MJ, Vilchez-Padial LM, Gil A, Gomez-Llorente C, Fontana L. Gene expression profiling in the intestinalmucosa of obese rats administered probiotic bacteria. Sci Data 2017;4:170186.
6. Metchnikoff E. The prolongation of life: optimistic studies. 1st ed. PC Mitchell, editor. New York, NY: G.P. Putnam's Sons; 1908.
7. Fontana L, Bermudez-Brito M, Plaza-Diaz J, Munoz-Quezada S, Gil A. Sources, isolation, characterisation and evaluation of probiotics. Br J Nutr 2013;109:35-50.
8. Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 1995;125:1401-12.
9. Ouwehand AC, Salminen S, Isolauri E. Probiotics: an overview of beneficial effects. Antonie Van Leeuwenhoek 2002;82:279-89.
10. Plaza-Diaz J, Robles-Sanchez C, Abadia-Molina F, Moron- Calvente V, Saez-Lara MJ, Ruiz-Bravo A, Jimenez-Valera M, Gil A, Gomez-Llorente C, Fontana L. Adamdec1, Ednrb and Ptgs1/Cox1, inflammation genes upregulated in the intestinalmucosa of obese rats, are downregulated by three probiotic strains. Sci Rep 2017;7:1939.
11. Tsilingiri K, Barbosa T, Penna G, Caprioli F, Sonzogni A, Viale G, Rescigno M. Probiotic and postbiotic activity in health and disease: comparison on a novel polarised ex-vivo organ culture model. Gut 2012;61:1007-15.
12. Didari T, Solki S, Mozaffari S, Nikfar S, Abdollahi M. A systematic review of the safety of probiotics. Expert Opin Drug Saf 2014;13:227-39.
13. SzajewskaH.What are the indications for using probiotics in children? Arch Dis Child 2016;101:398-403.
14. Hempel S, Newberry SJ, Maher AR, Wang Z, Miles JN, Shanman R, Johnsen B, Shekelle PG. Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA 2012;307:1959-69.
15. Moayyedi P, Ford AC, Talley NJ, Cremonini F, Foxx-Orenstein AE, Brandt LJ, Quigley EM. The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut 2010;59:325-32.
16. Goldenberg JZ, Yap C, Lytvyn L, Lo CK, Beardsley J, Mertz D, Johnston BC. Probiotics for the prevention of Clostridium difficileassociated diarrhea in adults and children. Cochrane Database Syst Rev 2017;12:CD006095.
17. Saez-Lara MJ, Gomez-Llorente C, Plaza-Diaz J, Gil A. The role of probiotic lactic acid bacteria and bifidobacteria in the prevention and treatment of inflammatory bowel disease and other related diseases: a systematic review of randomized human clinical trials. Biomed Res Int 2015:505878.
18. Rather IA, Bajpai VK, Kumar S, Lim J, Paek WK, Park YH. Probiotics and atopic dermatitis: an overview. Front Microbiol 2016;7:507.
19. Berings M, Karaaslan C, Altunbulakli C, Gevaert P, Akdis M, Bachert C, Akdis CA. Advances and highlights in allergen immunotherapy: on theway to sustained clinical and immunologic tolerance. JAllergyClin Immunol 2017;140:1250-67.
20. EFSA. Guidance on the scientific requirements for health claims related to the immune system, the gastrointestinal tract and defence against pathogenic microorganisms. EFSA J 2016;14:4369.
21. Degnan FH. The US Food and Drug Administration and probiotics: regulatory categorization. Clin Infect Dis 2008;46:S133-6.
22. FDA. Dietary supplements: New Dietary Ingredient notifications and related issues: guidance for industry, August 2016. [cited 2017 Oct 10]. Available from: http://www.fda.gov/downloads/Food/ GuidanceRegulation/GuidanceDocumentsRegulatoryInformation/ UCM515733.pdf.
23. Government of Canada. Health Canada [Internet]. [cited 2018 Jun 17]. a) Visbiome. Available from: https://health-products.canada. ca/lnhpd-bdpsnh/info.do?licence=80061901.
24. Bifidobacterium animalis spp. lactis LAFTI B94. Available from: https://healthproducts. canada.ca/lnhpd-bdpsnh/info.do?licence=80064384.
25. Byndloss MX, Baumler AJ. The germ-organ theory of noncommunicable diseases. Nat Rev Microbiol 2018;16:103-10.
26. Cani PD. Gut microbiota - at the intersection of everything? Nat Rev Gastroenterol Hepatol 2017;14:321-2.
27. Vieira AT, Fukumori C, Ferreira CM. New insights into therapeutic strategies for gut microbiota modulation in inflammatory diseases. Clin Transl Immunology 2016;5:e87.
28. Mendes MCS, Paulino DS, Brambilla SR, Camargo JA, Persinoti GF, Carvalheira JBC. Microbiota modification by probiotic supplementation reduces colitis associated colon cancer in mice. World J Gastroenterol 2018;24:1995-2008.
29. Yang I, Corwin EJ, Brennan PA, Jordan S, Murphy JR, Dunlop A. The infant microbiome: implications for infant health and neurocognitive development. Nurs Res 2016;65:76-88.
30. Hesla HM, Stenius F, Jaderlund L, Nelson R, Engstrand L, Alm J, Dicksved J. Impact of lifestyle on the gut microbiota of healthy infants and their mothers - the ALADDINbirth cohort. FEMSMicrobiol Ecol 2014;90:791-801.
31. Jimenez E, Fernandez L, Marin ML, Martin R, Odriozola JM, Nueno- Palop C, Narbad A, Olivares M, Xaus J, Rodriguez JM. Isolation of commensal bacteria from umbilical cord blood of healthy neonates born by cesarean section. Curr Microbiol 2005;51:270-4.
32. Aagaard K, Ma J, Antony KM, Ganu R, Petrosino J, Versalovic J. The placenta harbors a unique microbiome. Sci Transl Med 2014;6:237ra65.
33. Jimenez-Truque N, Tedeschi S, Saye EJ, McKenna BD, Langdon W, Wright JP, Alsentzer A, Arnold S, Saville BR, Wang W, et al. Relationship between maternal and neonatal Staphylococcus aureus colonization. Pediatrics 2012;129:e1252-9.
34. Murphy K, Curley D, O'Callaghan TF, O'Shea CA, Dempsey EM, O'Toole PW, Ross RP,Ryan CA, StantonC.The composition of human milk and infant faecal microbiota over the first three months of life: a pilot study. Sci Rep 2017;7:40597.
35. Martin R, Langa S, Reivierngo C, Jimenez E, Marin ML, Olivares M. The comensal microflora of human milk: new perspectives for food bacteriotherapy and probiotics. Trends Food Sci Tech 2004;15:121-7.
36. Ribet D, Cossart P. How bacterial pathogens colonize their hosts and invade deeper tissues. Microbes Infect 2015;17:173-83.
37. Hashemi A, Villa CR, Comelli EM. Probiotics in early life: a preventative and treatment approach. Food Funct 2016;7:1752-68.
38. Hojsak I, Szajewska H, Canani RB, Guarino A, Indrio F, Kolacek S, Orel R, Shamir R, Vandenplas Y, van Goudoever JB, et al. Probiotics for the prevention of nosocomial diarrhea in children. J Pediatr Gastroenterol Nutr 2018;66:3-9.
39. Bazanella M, Maier TV, Clavel T, Lagkouvardos I, Lucio M, Maldonado-GomezMX, Autran C,Walter J, Bode L, Schmitt-Kopplin P, et al. Randomized controlled trial on the impact of early-life intervention with bifidobacteria on the healthy infant fecal microbiota and metabolome. Am J Clin Nutr 2017;106:1274-86.
40. Berni Canani R, De Filippis F, Nocerino R, Laiola M, Paparo L, Calignano A, De Caro C, Coretti L, Chiariotti L, Gilbert J, et al. Specific signatures of the gut microbiota and increased levels of butyrate in children treated with fermented cow's milk containing heat-killed Lactobacillus paracasei CBA L74. Appl Environ Microbiol 2017;83:e01206-17.
41. Papadimitriou K, Zoumpopoulou G, Foligne B, Alexandraki V, Kazou M, Pot B, Tsakalidou E. Discovering probiotic microorganisms: in vitro, in vivo, genetic and omics approaches. Front Microbiol 2015;6:58.
42. Alfaleh K, Anabrees J. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev 2014;4:CD005496.
43. Olsen R, Greisen G, Schroder M, Brok J. Prophylactic probiotics for preterm infants: a systematic review and meta-analysis of observational studies. Neonatology 2016;109:105-12.
44. Xu M, Wang J, Wang N, Sun F, Wang L, Liu XH. The efficacy and safety of the probiotic bacterium Lactobacillus reuteri DSM 17938 for infantile colic: a meta-analysis of randomized controlled trials. PLoS One 2015;10:e0141445.
45. Chau K, Lau E, Greenberg S, Jacobson S, Yazdani-Brojeni P, Verma N, Koren G. Probiotics for infantile colic: a randomized, double-blind, placebo-controlled trial investigating Lactobacillus reuteri DSM17938. J Pediatr 2015;166:74-8.
46. Urbánska M, Szajewska H. The efficacy of Lactobacillus reuteri DSM 17938 in infants and children: a review of the current evidence. Eur J Pediatr 2014;173:1327-37.
47. Partty A, Lehtonen L, Kalliomaki M, Salminen S, Isolauri E. Probiotic Lactobacillus rhamnosus GG therapy and microbiological programming in infantile colic: a randomized, controlled trial. Pediatr Res 2015;78:470-5.
48. Urbánska M, Gieruszczak-Białek D, Szajewska H. Systematic review with meta-analysis: Lactobacillus reuteri DSM 17938 for diarrhoeal diseases in children. Aliment Pharmacol Ther 2016;43:1025-34.
49. Gil-Campos M, Lopez MA, Rodriguez-Benitez MV, Romero J, Roncero I, Linares MD, Maldonado J, Lopez-Huertas E, Berwind R, Ritzenthaler KL, et al. Lactobacillus fermentum CECT 5716 is safe and well tolerated in infants of 1-6months of age: a randomized controlled trial. Pharmacol Res 2012;65:231-8.
50. Korpela K, Salonen A, Virta LJ, Kumpu M, Kekkonen RA, de Vos WM.Lactobacillus rhamnosusGGintakemodifies preschool children's intestinal microbiota, alleviates penicillin-associated changes, and reduces antibiotic use. PLoS One 2016;25:e0154012.
51. Hong Chau TT,Minh Chau NN, Hoang Le NT, Chung The H, Voong Vinh P,Nguyen ToNT, Ngoc NM,TuanHM, ChauNgoc TL,Kolader ME, et al. A double-blind, randomized, placebo-controlled trial of Lactobacillus acidophilus for the treatment of acute watery diarrhea in Vietnamese children. Pediatr Infect Dis J 2018;37:35-42.
52. Hajare ST, Bekele G. Effect of probiotic strain Lactobacillus acidophilus (LBKV-3) on fecal residual lactase activity in undernourished children below 10 years. J Immunoassay Immunochem 2017;38:620-8.
53. DhamaK, Latheef SK,Munjal AK, KhandiaR, SamadHA, IqbalHMN, Joshi SK. Probiotics in curing allergic and inflammatory conditions - research progress and futuristic vision. Recent Pat Inflamm Allergy Drug Discov 2017;10:105-18.
54. He T, Priebe MG, Zhong Y, Huang C, Harmsen HJ, Raangs GC, Antoine JM,WellingGW,Vonk RJ. Effects of yogurt and bifidobacteria supplementation on the colonic microbiota in lactose-intolerant subjects. J Appl Microbiol 2008;104:595-604.
55. Oak SJ, Jha R. The effects of probiotics in lactose intolerance: a systematic review. Crit Rev Food Sci Nutr 2018:1-9.
56. Azcarate-Peril MA, Ritter AJ, Savaiano D, Monteagudo-Mera A, Anderson C, Magness ST, Klaenhammer TR. Impact of short-chain galactooligosaccharides on the gut microbiome of lactose-intolerant individuals. Proc Natl Acad Sci U S A 2017;114:E367-75.
57. West CE, Jenmalm MC, Prescott SL. The gut microbiota and its role in the development of allergic disease: a wider perspective. Clin Exp Allergy 2015;45:43-53.
58. Zhang GQ, Hu HJ, Liu CY, Zhang Q, Shakya S, Li ZY. Probiotics for prevention of atopy and food hypersensitivity in early childhood: a PRISMA-compliant systematic review and meta-analysis of randomized controlled trials. Medicine (Baltimore) 2016;95:e2562.
59. Lifschitz C, Szajewska H. Cow'smilk allergy: evidence-based diagnosis and management for the practitioner. Eur J Pediatr 2015;174:141-50.
60. Vandenplas Y. Prevention and management of cow's milk allergy in non-exclusively breastfed infants. Nutrients 2017;9:E731.
61. Bunyavanich S, Shen N, Grishin A, Wood R, Burks W, Dawson P, Jones SM, Leung DYM, Sampson H, Sicherer S, et al. Early-life gut microbiome composition and milk allergy resolution. J Allergy Clin Immunol 2016;138:1122-30.
62. Berni Canani R, Sangwan N, Stefka AT, Nocerino R, Paparo L, Aitoro R, Calignano A, Khan AA, Gilbert JA, Nagler CR. Lactobacillus rhamnosus GG-supplemented formula expands butyrate-producing bacterial strains in food allergic infants. ISME J 2016;10:742-50.
63. Olivares M, Diaz-Ropero MA, Gomez N, Lara-Villoslada F, Sierra S, Maldonado JA, Martin R, Lopez-Huertas E, Rodriguez JM, Xaus J. Oral administration of two probiotic strains, Lactobacillus gasseri CECT5714 and Lactobacillus coryniformis CECT5711, enhances the intestinal function of healthy adults. Int J Food Microbiol 2006;107:104-11.
64. Wind RD, Tolboom H, Klare I, Huys G, Knol J. Tolerance and safety of the potentially probiotic strain Lactobacillus rhamnosus PRSFL477: a randomised, double-blind placebo-controlled trial in healthy volunteers. Br J Nutr 2010;104:1806-16.
65. Sierra S, Lara-Villoslada F, Sempere L, Olivares M, Boza J, Xaus J. Intestinal and immunological effects of daily oral administration of Lactobacillus salivarius CECT5713 to healthy adults. Anaerobe 2010;16:195-200.
66. Plaza-Diaz J, Gomez-Llorente C, Campana-Martin L, Matencio E, Ortuno I, Martinez-Silla R, Gomez-Gallego C, Periago MJ, Ros G, Chenoll E, et al. Safety and immunomodulatory effects of three probiotic strains isolated fromthe feces of breast-fed infants in healthy adults: SETOPROB study. PLoS One 2013;8:e78111.
67. Rajkumar H, Mahmood N, Kumar M, Varikuti SR, Challa HR, Myakala SP. Effect of probiotic (VSL#3) and omega-3 on lipid profile, insulin sensitivity, inflammatory markers, and gut colonization in overweight adults: a randomized, controlled trial. Mediators Inflamm 2014:348959.
68. Sharafedtinov KK, Plotnikova OA, Alexeeva RI, Sentsova TB, Songisepp E, Stsepetova J, Smidt I, Mikelsaar M. Hypocaloric diet supplemented with probiotic cheese improves body mass index and blood pressure indices of obese hypertensive patients - a randomized double-blind placebo-controlled pilot study. Nutr J 2013; 12:138.
69. Ganji-Arjenaki M, Rafieian-Kopaei M. Probiotics are a good choice in remission of inflammatory bowel diseases: a meta analysis and systematic review. J Cell Physiol 2018;233:2091-103.
70. Geirnaert A, Calatayud M, Grootaert C, Laukens D, Devriese S, Smagghe G, De Vos M, Boon N, Van de Wiele T. Butyrate-producing bacteria supplemented in vitro to Crohn's disease patient microbiota increased butyrate production and enhanced intestinal epithelial barrier integrity. Sci Rep 2017;7:11450.
71. Johnston BC, Ma SS, Goldenberg JZ, Thorlund K, Vandvik PO, Loeb M, Guyatt GH. Probiotics for the prevention of Clostridium difficileassociated diarrhea: a systematic reviewandmeta-analysis. Ann Intern Med 2012;157:878-88.
72. Bermudez-Brito M, Plaza-Diaz J,Munoz-Quezada S, Gomez-Llorente C, Gil A. Probiotic mechanisms of action. Ann Nutr Metab 2012;61:160-74.
73. Collado MC, Gueimonde M, Salminem S. Probiotics in adhesion of pathogens: mechanisms of action. In: RRWatson, VR Preedy, editors. Bioactive foods in promoting health: probiotics and prebiotics. 1st ed. London: Academic Press, Elsevier; 2010. p. 353-70.
74. Munoz-Quezada S, Bermudez-BritoM, ChenollE,Genoves S, Gomez- Llorente C, Plaza-Diaz J, Matencio E, Bernal MJ, Romero F, Ramon D, et al. Competitive inhibition of three novel bacteria isolated from faeces of breast milk-fed infants against selected enteropathogens. Br J Nutr 2013;109:S63-9.
75. Kumar M, Nagpal R, Verma V, Kumar A, Kaur N, Hemalatha R, Gautam SK, Singh B. Probiotic metabolites as epigenetic targets in the prevention of colon cancer. Nutr Rev 2013;71:23-34.
76. Umu OCO, Rudi K, Diep DB. Modulation of the gut microbiota by prebiotic fibres and bacteriocins. Microb Ecol Health Dis 2017;28:1348886.
77. Mokoena MP. Lactic acid bacteria and their bacteriocins: classification, biosynthesis and applications against uropathogens: a mini-review. Molecules 2017;22:1255.
78. Kumar M, Dhaka P, Vijay D, Vergis J, Mohan V, Kumar A, Kurkure NV, Barbuddhe SB, Malik SVS, Rawool DB. Antimicrobial effects of Lactobacillus plantarum and Lactobacillus acidophilus against multidrug-resistant enteroaggregative Escherichia coli. Int J Antimicrobial Agents 2016;48:265-70.
79. Kim DH, Jin YH. Intestinal bacterial beta-glucuronidase activity of patients with colon cancer. Arch Pharm Res 2001;24:564-7.
80. Kulkarni N, Reddy BS. Inhibitory effect of Bifidobacterium longum cultures on the azoxymethane-induced aberrant crypt foci formation and fecal bacterial β-glucuronidase. Exptal BiolMed 1994;207:278-83.
81. Buss C, Valle-Tovo C, Miozzo S, Alves de Mattos A. Probiotics and synbiotics may improve liver aminotransferases levels in non-alcoholic fatty liver disease patients. Ann Hepatol 2014;13:482-8.
82. Pavlović N, Stankov K, Mikov M. Probiotics - interactions with bile acids and impact on cholesterolmetabolism.Appl Biochem Biotechnol 2012;168:1880-95.
83. Kumar R, Grover S, Batish VK. Hypocholesterolaemic effect of dietary inclusion of two putative probiotic bile salt hydrolase-producing Lactobacillus plantarum strains in Sprague-Dawley rats. Br J Nutr 2011;105:561-73.
84. Macfarlane S, Macfarlane GT. Regulation of short-chain fatty acid production. Proc Nutr Soc 2003;62:67-72.
85. Ferrario C, Taverniti V, Milani C, Fiore W, Laureati M, De Noni I, Stuknyte M, Chouaia B, Riso P, Guglielmetti S. Modulation of fecal Clostridiales bacteria and butyrate by probiotic intervention with Lactobacillus paracasei DG varies among healthy adults. J Nutr 2014;144:1787-96.
86. Wang L, Zhang J, Guo Z, Kwok L, Ma C, Zhang W, Lv Q, Huang W, Zhang H. Effect of oral consumption of probiotic Lactobacillus plantarum P-8 on fecal microbiota, SIgA, SCFAs, and TBAs of adults of different ages. Nutrition 2014;30:776-83.
87. Worthley DL, Le Leu RK, Whitehall VL, Conlon M, Christophersen C, Belobrajdic D, Mallitt KA, Hu Y, Irahara N, Ogino S, et al. A human, double-blind, placebo-controlled, crossover trial of prebiotic, probiotic, and synbiotic supplementation: effects on luminal, inflammatory, epigenetic, and epithelial biomarkers of colorectal cancer. Am J Clin Nutr 2009;90:578-86.
88. Macfarlane S, Cleary S, Bahrami B, Reynolds N, Macfarlane GT. Synbiotic consumption changes the metabolism and composition of the gut microbiota in older people and modifies inflammatory processes: a randomised, double-blind, placebo-controlled crossover study. Aliment Pharmacol Ther 2013;38:804-16.
89. Schneider SM, Girard-Pipau F, Filippi J, Hebuterne X, Moyse D, HinojosaGC, Pompei A, Rampal P. Effects of Saccharomyces boulardii on fecal short-chain fatty acids andmicroflora in patients on long-term total enteral nutrition.World J Gastroenterol 2005;11:6165-9.
90. Wullt M, Johansson Hagslatt ML, Odenholt I, Berggren A. Lactobacillus plantarum 299v enhances the concentrations of fecal short-chain fatty acids in patients with recurrent Clostridium difficile-associated diarrhea. Dig Dis Sci 2007;52:2082-6.
91. Nagata S, Asahara T, Ohta T, Yamada T, Kondo S, Bian L, Wang C, Yamashiro Y, Nomoto K. Effect of the continuous intake of probiotic-fermented milk containing Lactobacillus casei strain Shirota on fever in a mass outbreak of norovirus gastroenteritis and the faecal microflora in a health service facility for the aged. Br J Nutr 2011;106: 549-56.
92. Nagata S, Asahara T, Wang C, Suyama Y, Chonan O, Takano K, Daibou M, Takahashi T, Nomoto K, Yamashiro Y. The effectiveness of Lactobacillus beverages in controlling infections among the residents of an aged care facility: a randomized placebo-controlled double-blind trial. Ann Nutr Metab 2016;68:51-9.
93. Hemalatha R, Ouwehand AC, Saarinen MT, Prasad UV, Swetha K, Bhaskar V. Effect of probiotic supplementation on total lactobacilli, bifidobacteria and short chain fatty acids in 2-5-year-old children. Microb Ecol Health Dis 2017;10:1298340.
94. Riezzo G, Orlando A, D'Attoma B, Guerra V, Valerio F, Lavermicocca P, De Candia S, Russo F. Randomised clinical trial: efficacy of Lactobacillus paracasei-enriched artichokes in the treatment of patients with functional constipation - a double-blind, controlled, crossover study. Aliment Pharmacol Ther 2012;35:441-50.
95. Maldonado J, Lara-Villoslada F, Sierra S, Sempere L, Gomez M, Rodriguez JM, Boza J, Xaus J, Olivares M. Safety and tolerance of the human milk probiotic strain Lactobacillus salivarius CECT5713 in 6- month-old children. Nutrition 2010;26:1082-7.
96. MohanR, KoebnickC, Schildt J,MuellerM, RadkeM,BlautM. Effects of Bifidobacterium lactis Bb12 supplementation on body weight, fecal pH, acetate, lactate, calprotectin, and IgA in preterm infants. Pediatr Res 2008;64:418-22.
97. Underwood MA, Salzman NH, Bennett SH, Barman M, Mills DA, Marcobal A, Tancredi DJ, Bevins CL, Sherman MP. A randomized placebo-controlled comparison of 2 prebiotic/probiotic combinations in preterm infants: impact on weight gain, intestinal microbiota, and fecal short-chain fatty acids. J PediatrGastroenterolNutr 2009;48:216-25.
98. Saez-Lara MJ, Robles-Sanchez C, Ruiz-Ojeda FJ, Plaza-Diaz J, Gil A. Effects of probiotics and synbiotics on obesity, insulin resistance syndrome, type 2 diabetes and non-alcoholic fatty liver disease: a review of human clinical trials. Int J Mol Sci 2016;17:928.
99. Larsen N, Vogensen FK, Gobel RJ, Michaelsen KF, Forssten SD, Lahtinen SJ, Jakobsen M. Effect of Lactobacillus salivarius Ls-33 on fecal microbiota in obese adolescents. Clin Nutr 2013;32:935-40.
100. Miccheli A, Capuani G, Marini F, Tomassini A, Pratico G, Ceccarelli S, Gnani D, Baviera G, Alisi A, Putignani L, et al. Urinary (1)H-NMRbased metabolic profiling of children with NAFLD undergoing VSL#3 treatment. Int J Obes (Lond) 2015;39:1118-25.
101. Plaza-Diaz J, Gomez-Llorente C, Abadia-Molina F, Saez-Lara MJ, Campana-Martin L, Munoz-Quezada S, Romero F, Gil A, Fontana L. Effects of Lactobacillus paracasei CNCMI-4034, Bifidobacterium breve CNCM I-4035 and Lactobacillus rhamnosus CNCM I-4036 on hepatic steatosis in Zucker rats. PLoS One 2014;9:e98401.
102. Canfora EE, Jocken JW, Blaak EE. Short-chain fatty acids in control of body weight and insulin sensitivity. Nat Rev Endocrinol 2015;11:577-91.
103. Fukuda S, Toh H, Hase K, Oshima K, Nakanishi Y, Yoshimura K, Tobe T, Clarke JM, Topping DL, Suzuki T, et al. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 2011;469:543-7.
104. Hur KY, Lee MS. Gut microbiota and metabolic disorders. Diabetes Metab J 2015;39:198-203.
105. Kim HK, Rutten NB, Besseling-van der Vaart I, Niers LE, Choi YH, RijkersGT, vanHemert S. Probiotic supplementation influences faecal short chain fatty acids in infants at high risk for eczema. Benef Microbes 2015;m6:783-90.
106. Yadav AK, Tyagi A, Kumar A, Panwar S, Grover S, Saklani AC, Hemalatha R, Batish VK. Adhesion of lactobacilli and their antiinfectivity potential. Crit Rev Food Sci Nutr 2017;57:2042-56.
107. Van Tassell ML,MillerMJ. Lactobacillus adhesion tomucus. Nutrients 2011;3:613-36.
108. Buck BL, Altermann E, Svingerud T, Klaenhammer TR. Functional analysis of putative adhesion factors in Lactobacillus acidophilus NCFM. Appl Environ Microbiol 2005;71:8344-51.
109. Dicks LM, Botes M. Probiotic lactic acid bacteria in the gastrointestinal tract: health benefits, safety and mode of action. Benef Microbes 2010;1:11-29.
110. Lenaerts K, Bouwman FG, Lamers WH, Renes J, Mariman EC. Comparative proteomic analysis of cell lines and scrapings of the human intestinal epithelium. BMC Genomics 2007;8:91.
111. Huang SH,He L, Zhou Y,Wu CH, JongA. Lactobacillus rhamnosusGG suppresses meningitic E. coli K1 penetration across human intestinal epithelial cells in vitro and protects neonatal rats against experimental hematogenous meningitis. Int J Microbiol 2009:647862.
112. Zhang W, Zhu YH, Yang JC, Yang GY, Zhou D, Wang JF. A selected Lactobacillus rhamnosus strain promotes Egfr-independent Akt activation in an enterotoxigenic Escherichia coli k88-infected IPEC-J2 cell model. PLoS One 2015;10:e0125717.
113. Mujagic Z, de Vos P, Boekschoten MV, Govers C, Pieters HH, de Wit NJ, Bron PA, Masclee AA, Troost FJ. The effects of Lactobacillus plantarum on small intestinal barrier function and mucosal gene transcription; a randomized double-blind placebo controlled trial. Sci Rep 2017;7:40128.
114. D'Amelio P, Sassi F. Gut microbiota, immune system, and bone. Calcif Tissue Int 2017;102(4):415-25.
115. Gomez-Llorente C, Munoz S, Gil A. Role of toll-like receptors in the development of immunotolerance mediated by probiotics. Proc Nutr Soc 2010;69:381-9.
116. Claes AK, Zhou JY, Philpott DJ. NOD-like receptors: guardians of intestinal mucosal barriers. Physiology (Bethesda) 2015;30:241-50.
117. Hevia A, Delgado S, Sanchez B, Margolles A. Molecular players involved in the interaction between beneficial bacteria and the immune system. Front Microbiol 2015;6:1285.
118. Yousefi M, Movassaghpour AA, Shamsasenjan K, Ghalamfarsa G, Sadreddini S, Jadidi-Niaragh F, Hojjat-Farsangi M. The skewed balance between Tregs and Th17 in chronic lymphocytic leukemia. Future Oncol 2015;11:1567-82.
119. Giorgetti G, Brandimarte G, Fabiocchi F, Ricci S, Flamini P, Sandri G, Trotta MC, Elisei W, Penna A, Lecca PG, et al. Interactions between innate immunity, microbiota, and probiotics. J Immunol Res 2015:501361.
120. Wang H, Gao K, Wen K, Allen IC, Li G, Zhang W, Kocher J, Yang X, Giri-Rachman E, Li GH, et al. Lactobacillus rhamnosus GG modulates innate signaling pathway and cytokine responses to rotavirus vaccine in intestinal mononuclear cells of gnotobiotic pigs transplanted with human gut microbiota. BMC Microbiol 2016;16(1):109.
121. Harbige LS, Pinto E, Allgrove J, Thomas LV. Immune response of healthy adults to the ingested probiotic Lactobacillus casei Shirota. Scand J Immunol 2016;84:353-64.
122. Letnicka A, Karaffova V, Levkut M, Revajova V, Herich R. Influence of oral application of Enterococcus faecium AL41 on TGF-β4 and IL- 17 expression and immunocompetent cell distribution in chickens challenged with Campylobacter jejuni. Acta Vet Hung 2017;65:317-26.
123. Dogi C, Garcia G, De Moreno de LeBlanc A, Greco C, Cavaglieri L. Lactobacillus rhamnosus RC007 intended for feed additive: immunestimulatory properties and ameliorating effects on TNBS-induced colitis. Benef Microbes 2016;7:539-47.
124. Takeda S, Kawahara S, Hidaka M, Yoshida H,WatanabeW, Takeshita M, Kikuchi Y, Bumbein D, Muguruma M, Kurokawa M. Effects of oral administration of probiotics from Mongolian dairy products on the Th1 immune response in mice. Biosci Biotechnol Biochem 2013;77:1372-8.
125. Aktas B, De Wolfe TJ, Safdar N, Darien BJ, Steele JL. The impact of Lactobacillus casei on the composition of the cecal microbiota and innate immune system is strain specific. PLoS One 2016;11:e0156374.
126. O'Mahony C, Scully P, O'Mahony D, Murphy S, O'Brien F, Lyons A, Sherlock G, MacSharry J, Kiely B, Shanahan F, et al. Commensalinduced regulatory T cells mediate protection against pathogenstimulated NF-κB activation. PLoS Pathog 2008;4:e1000112.
127. Thomas LV, Suzuki K, Zhao J. Probiotics: a proactive approach to health. A symposium report. Br J Nutr 2015;114:S1-15.
128. Heuvelin E, Lebreton C, Grangette C, Pot B, Cerf-Bensussan N, Heyman M. Mechanisms involved in alleviation of intestinal inflammation by Bifidobacterium breve soluble factors. PLoS One 2009;4:e5184.
129. Pagnini C, Saeed R, Bamias G, Arseneau KO, Pizarro TT, Cominelli F. Probiotics promote gut health through stimulation of epithelial innate immunity. Proc Natl Acad Sci U S A 2010;107:454-9.
130. Kwon HK, Lee CG, So JS, Chae CS, Hwang JS, Sahoo A, Nam JH, Rhee JH, Hwang KC, Im SH. Generation of regulatory dendritic cells and CD4+Foxp3+ T cells by probiotics administration suppresses immune disorders. Proc Natl Acad Sci U S A 2010;107:2159-64.
131. Wells JM. Immunomodulatory mechanisms of lactobacilli. Microb Cell Fact 2011;10:S17.
132. Vinderola G, Matar C, Perdigon G. Role of the epithelial cells in the immune effects mediated by gram-positive probiotic bacteria. Involvement of toll-like receptors. Clin Diagn Lab Immunol 2005;12:1075-84.
133. Ren C, Zhang Q, de Haan BJ, Zhang H, Faas MM, de Vos P. Identification of TLR2/TLR6 signalling lactic acid bacteria for supporting immune regulation. Sci Rep 2016;6:34561.
134. Shida K, Kiyoshima-Shibata J, Nagaoka M, Nanno M. Peptidoglycan from lactobacilli inhibits interleukin-12 production by macrophages induced by Lactobacillus casei through toll-like receptor 2-dependent and independent mechanisms. Inmmunology 2009;128:e858-69.
135. AbreuMT, Fukata M, Arditi M. TLR signaling in the gut in health and diseases. J Immunol 2005;174:4453-60.
136. Castillo NA, Perdigon G, De Moreno de Le Blanc A. Oral administration of a probiotic Lactobacillus modulates cytokine production and TLR expression improving the immune response against Salmonella enterica serovar typhimurium infection in mice. BMC Microbiol 2011;11:177-89.
137. Karczewski J, Troost FJ, Konings I, Dekker J, Kleerebezem M, Brummer RJ,Wells JM. Regulation of human epithelial tight junction proteins by Lactobacillus plantarum in vivo and protective effects on the epithelial barrier. Am J Physiol Gastrointest Liver Physiol 2010;298:G851-9.
138. Compare D, Rocco A, Coccoli P, Angrisani D, Sgamato C, Iovine B, Salvatore U, Nardone G. Lactobacillus casei DG and its postbiotic reduce the inflammatory mucosal response: an ex-vivo organ culture model of post-infectious irritable bowel syndrome. BMC Gastroenterol 2017;17:53.
139. Hoarau C, Martin L, Faugaret D, Baron C, Dauba A, Aubert-Jacquin C, Velge-Roussel F, Lebranchu Y. Supernatant from Bifidobacterium differentiallymodulates transduction signaling pathways for biological functions of human dendritic cells. PLoS One 2008;3:e2753.
140. Zeuthen LH, Fink LN, Frokiaer H. Toll-like receptor 2 and nucleotidebinding oligomerization domain-2 play divergent roles in the recognition of gut derived lactobacilli and bifidobacteria in dendritic cells. Inmmunology 2008;124:489-502.
141. Kailova L, Mount Patrick SK, Arganbright KM, Halpern M, Kinouchi T, Dvorak B. Bifidobacterium bifidum reduces apoptosis in the intestinal epithelium in necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 2010;299:G1118-27.
142. Tang Y, Wu Y, Huang Z, Dong W, Deng Y, Wang F, Li M, Yuan J. Administration of probiotic mixture DM#1 ameliorated 5-fluorouracil-induced intestinal mucositis and dysbiosis in rats. Nutrition 2017;33:96-104.
143. Lee J, Mo JH, Katura K, Alkalay I, Rucker AN, Liu YT, Lee HK, Shen C, Cojocaru G, Shenouda S, et al.Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells. Nat Cell Biol 2006;8:1327-36.
144. Plantiga TS, vanMarenWWC, van Bergenhenegouwen J,Hameetman M, Nierkens S, Jacobs C, de Jong DJ, Joosten LAB, van't Land B, Garssen J, et al. Differential toll-like receptor recognition and induction of cytokine profile by Bifidobacterium breve and Lactobacillus strains of probiotics. Clin Vaccine Immunol 2011;18:621-8.
145. Kim CH, Kim HG, Kim JY, Kim NR, Jung BJ, Jeong JH, Chung DK. Probiotic genomic DNA reduces the production of proinflammatory cytokine tumor necrosis factor-alpha. FEMS Microbiol Lett 2012;328:13-19.
146. Bermudez-Brito M, Munoz-Quezada S, Gomez-Llorente C, Matencio E, Romero F, Gil A. Lactobacillus paracasei CNCM I-4034 and its culture supernatant modulate Salmonella-induced inflammation in a novel transwell co-culture of human intestinal-like dendritic and Caco-2 cells. BMC Microbiol 2015;15:79.
147. Good M, Sodhi CP, Ozolek JA, Buck RH, Goehring KC, Thomas DL, Vikram A, Bibby K, Morowitz MJ, Firek B, et al. Lactobacillus rhamnosus HN001 decreases the severity of necrotizing enterocolitis in neonatal mice and preterm piglets: evidence in mice for a role of TLR9. Am J Physiol Gastrointest Liver Physiol 2014;306:G1021-32.
148. Tung J, Barreiro LB, Burns MB, Grenier JC, Lynch J, Grieneisen LE, Altmann J, Alberts SC, Blekhman R, Archie EA. Social networks predict gut microbiome composition in wild baboons. ELife 2015;4:e05224.
149. Vuong HE, Yano JM, Fung TC, Hsiao EY. The microbiome and host behavior. Annu Rev Neurosci 2017;40:21-49.
150. Tillisch K, Labus J, Kilpatrick L, Jiang Z, Stains J, Ebrat B, Guyonnet D, Legrain-Raspaud S, Trotin B, Naliboff B, et al. Consumption of fermented milk product with probiotic modulates brain activity. Gastroenterology 2013;144:1394-401.
151. Cong X, Xu W, Romisher R, Poveda S, Forte S, Starkweather A, Henderson WA. Gut microbiome and infant health: brain-gutmicrobiota axis and host genetic factors. Yale J BiolMed 2016;89:299-308.
152. Bonaz BL, Bernstein CN. Brain-gut interactions in inflammatory bowel disease. Gastroenterology 2013;144:36-49.
153. Arboleya S, Salazar N, Solis G, Fernandez N, Hernandez-Barranco AM, Cuesta I, Gueimonde M, de los Reyes-Gavilan CG. Assessment of intestinal microbiota modulation ability of Bifidobacterium strains in in vitro fecal batch cultures from preterm neonates. Anaerobe 2013;19:9-16.
154. Yang Y, Tian J,Yang B. Targeting gut microbiome: a novel and potential therapy for autism. Life Sci 2017;194:111-19.
155. Hsiao EY, McBride SW, Hsien S, Sharon G, Hyde ER, McCue T, Codelli JA, Chow J, Reisman SE, Petrosino JF, et al. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell 2013;155: 1451-63.
156. Li M, Fallin MD, Riley A, Landa R,Walker SO, Silverstein M, Caruso D, Pearson C, Kiang S, Dahm JL, et al. The association of maternal obesity and diabetes with autism and other developmental disabilities. Pediatrics 2016;137:e20152206.
157. Nahum Sacks K, Friger M, Shoham-Vardi I, Abokaf H, Spiegel E, Sergienko R, Landau D, Sheiner E. Prenatal exposure to gestational diabetes mellitus as an independent risk factor for long-term neurologic morbidity of the offspring. Am J Obstet Gynecol 2016;214:S48-9.
158. Buffington SA, Di Prisco GV, Auchtung TA, Ajami NJ, Petrosino JF, Costa-Mattioli M. Microbial reconstitution reverses maternal dietinduced social and synaptic deficits in offspring. Cell 2016;165:1762-75.
159. Dinan TG, Quigley EM, Ahmed SM, Scully P, O'Brien S, O'Mahony L, O'Mahony S, Shanahan F, Keeling PW. Hypothalamic-pituitarygut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker? Gastroenterology 2006;130: 304-11.
160. Messaoudi M, Lalonde R, Violle N, Javelot H, Desor D, Nejdi A, Bisson JF, Rougeot C, Pichelin M, Cazaubiel M, et al. Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. Br J Nutr 2011;105:755-64.
161. de la Fuente-Nunez C, Meneguetti BT, Franco OL, Lu TK. Neuromicrobiology: how microbes influence the brain. ACS Chem Neurosci 2018;9(2):141-50.
162. Ong IM, Gonzalez JG, McIlwain SJ, Sawin EA, Schoen AJ, Adluru N, Alexander AL, Yu JJ. Gut microbiome populations are associated with structure-specific changes in white matter architecture. Transl Psychiatry 2018;8:6.